| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.26 | 3e-08 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.083 | 0.06 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.07 | 0.09 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.076 | 0.1 |